MedTrace Logo

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

NCT04067583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 454

Last updated 2021-04-08

No results posted yet for this study

Summary

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

Conditions

  • Ophthalmology, Macular Degeneration

Interventions

OTHER

Physician questionnaire

This is a one-time cross-sectional survey of physicians, conducted electronically; there are no in person visits

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-08
Primary Completion
2020-04-15
Completion
2020-04-23

Countries

  • Germany

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067583 on ClinicalTrials.gov